printed copy

The Coming Cancer Breakthroughs

Joseph F. Dooley. Ph.D., Marian Betancourt

ISBN 1575668432
Publish Date 6/1/2002
Format Hardcover
Categories Kensington, Traditional
Currently out of stock

Until recently, a diagnosis of cancer often meant a death sentence. Today, there are approximately 8.2 million cancer survivors in the United States, with many more joining their ranks every year.

Thanks to rapid advances in biotechnology, a whole new generation of sophisticated cancer drugs has been born. These drugs are helping people with many types of cancer live longer than ever before. And because they often have few side effects, patients can live normal lives while undergoing treatment.

And yet with all of these revolutionary changes taking place, many are unaware of the exciting new treatment options available to them. Now that information is brought together in The Coming Cancer Breakthroughs. Written by leading biochemist Joseph Dooley, Ph.D., FACB, and author and cancer survivor Marian Betancourt, this is the first book to fully document the tremendous strides being made in cancer research, and offers real hope to those who need it most.

Written in plain language specifically for cancer patients, this comprehensive and compassionate book clearly explains how the exciting new medical breakthroughs work and how they are being used to treat specific forms of cancer, with details of the most-up-to-date therapies for each, from breast and colon cancer, to cancer of the prostate and lung.

  • You'll learn how to talk to your doctor to ensure he or she is aware of the newest and most promising treatment options

  • You'll discover how you can participate in clinical trials being conducted across the country and around the world

  • You'll get reports from more than 30 healthcare professionals on the results they've seen in their patients

  • You'll hear the personal stories of real cancer patients who have taken advantage of the latest clinical advances

It also includes a complete glossary of terms, and an extensive directory of addresses and phone numbers for many of the top biotech companies conducting clinical trials and research. It even tells you where to find financial aid to pay for your treatments.

When you're fighting cancer, you need the latest information. The Coming Cancer Breakthroughs arms you with knowledge that empowers, so you can take the offensive—and win.

Joseph Dooley, Ph.D., FACB, is a licensed, board-certified clinical biochemist with more than twenty-five years of experience in cutting-edge medical science. Dr. Dooley is a scientist, entrepreneur, and writer who founded a worldwide biotechnology consulting firm, Biotechnology Associates. He has been director and CEO of several nationally prominent laboratories, and is a respected international consultant on clinical diagnostics, as well as an in-demand public lecturer and teacher. Dr. Dooley is the author of more than thirty professional publications, two patents, and over forty monographs on biotechnology and medical devices. He is a Fellow of the Academy of Clinical Biochemistry and lives in Waterford, Connecticut.

Marian Betancourt is the author of seven books on cancer and health, including What to Do If You Get Breast Cancer, which was based on her own experiences. Her work has been reviewed in the New York Times and featured on Oprah! and Montel. She lives in Brooklyn, New York.

Real People Who Got A Second Chance With Today's Cutting-Edge Cancer Treatments

Don, 51, was given four months to live when doctors found a tumor the size of a tennis ball in his pancreas. Then he learned about a trial that was beginning human testing on Rubitecan, an extraordinary compound that stops cancer cells from dividing. Within six weeks of taking the drug, Gordon's deadly tumor had shrunk to the size of a golf ball. Four years later, he tells everyone who will listen, “All that's left of that tumor is some scar tissue.”

Cindy, a mother of three young children, was diagnosed with incurable non-Hodgkins lymphoma, which had spread throughout her body. When doctors told her that conventional treatments would not work, she joined the clinical trial of a drug called Rituxan, the nation's first genetically-engineered monoclonal antibody—and greatly increased her chances for survival. “Rituxan has renewed my hope of raising my three children,” Wendy said.

Lynn, 58, was diagnosed with breast cancer that had spread to her lymph nodes. Even after chemotherapy and radiation there were still signs of cancer in her bones and other parts of her body. “At first, I just wanted to go home and die,” Joycelin said. But then she found the courage to fight and got herself into a clinical trial of Herceptin, a breakthrough drug with few side effects. Before long, the signs of cancer in her vertebrae and pelvis had receded.

View Introduction

Average Customer Review

Based on 0 reviews

Write a Review